NorthWest Biotherapeutics Inc (NWBO)

[Pablosrv]

What do you mean? It says it right here:

https://higherlogicdownload.s3.amazonaws.com/SITCANCER/46eb96a3-a32e-41a0-90c9-f47172eef564/UploadedImages/Reimagined_Abstract_Reference_Guide.pdf

Late-Breaking Abstract Information and Eligibility
Late-breaking abstract submission is solely for abstracts with late-breaking data and not for abstracts
submitted “late.” The late-breaking abstract deadline is not intended to be an extension of the general
submission deadline. Late-breaking abstracts highlight novel and practice-changing studies, and only
apply to data that would have not otherwise have been presented as an abstract at the 35th Anniversary
Annual Meeting.
Examples of acceptable late-breaking abstracts include the following (in each case, results were not
available or significant by the regular abstract submission deadline):
? Results of a practice-changing prospective Phase III clinical trial
? Phase II study showing anti-tumor activity in a novel context
? An early clinical trial with novel proof-of-principle data
? Demonstration of novel cancer biology with therapeutic implications